Site-Wide License
Showing 229–240 of 279 results
-
Liver Cancer: Disease and Pipeline Analysis
$2,960.00 – $5,920.00 -
EDC and ePRO Market Trends and Service Provider Performance
$4,900.00 – $9,800.00 -
Phase I Study Trends and Market Outlook (2013)
$4,900.00 – $9,800.00 -
Risk-based Monitoring: Industry Guidance on Adoption, Use, and Outsourcing
$3,260.00 – $6,520.00 -
CRO Quality Benchmarking – Phase II/III Service Providers (5th edition)
$6,800.00 – $13,600.00 -
Medical Device: Clinical Development Market Assessment
$3,960.00 – $7,920.00 -
Pancreatic Cancer: Disease and Pipeline Analysis
$2,960.00 – $5,920.00 -
Sunshine Act: Pharma Impact – Changes in US Physician Behavior
$4,900.00 – $9,800.00 -
Late Phase Market Overview and Outlook (2013)
$4,900.00 – $9,800.00 -
Biosimilar Primer: US Primary Care Physicians’ Attitudes, Beliefs, and Intentions
$750.00 – $1,500.00 -
Social Media: Best Practices and Strategic Use in Patient Recruitment
$4,900.00 – $9,800.00 -
Adoption and Use of eDetailing vs. In-person Detailing in Europe
$4,900.00 – $9,800.00